MSMarie-Claire Seeley — no licensed photograph is available, so the academic plate is shown instead.

Academic

Marie-Claire Seeley

Press citations

3

Topic

1

Long Covid

Last quoted

Sept 2026

Marie-Claire Seeley: key facts

Kind of voice
Academic
Quoted on
Long Covid
Tracked press citations
3
Most recently quoted
30 Sept 2026

“Researcher urges autonomic assessment for patients with Long COVID, discussing standing tests, medication review, and what inflammatory findings may mean for future POTS treatment”

What Marie-Claire Seeley has said

Where Marie-Claire Seeley has been quoted

  1. Positive Phase 2a Trial Data Support FDA Clearance of StemCyte’s HPC Therapy for Long COVIDpharmacytimes.com · 30 Sept 2026
  2. Night Shift Work, Chronic Insomnia Nearly Triple Long-COVID Risk, Study Findspharmacytimes.com · 30 Sept 2026
  3. Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTSpharmacytimes.com · 29 Sept 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.